Pzena Investment Management’s Halozyme HALO Stock Holding History

Pzena Investment Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Hold	4,049	–	–	﹤0.01%	147
2026 Q1	$262K	Sell	4,049 -229	-5%	-$16.1K	﹤0.01%	152
2025 Q4	$288K	Buy	4,278 +171	+4%	+$11.5K	﹤0.01%	152
2025 Q3	$301K	Buy	+4,107	New	+$273K	﹤0.01%	144
2023 Q2	–	Sell	-9,216	Closed	-$352K	–	165
2023 Q1	$352K	Sell	9,216 -5,291	-36%	-$248K	﹤0.01%	153
2022 Q4	$825K	Buy	+14,507	New	+$743K	﹤0.01%	140
2022 Q2	–	Sell	-15,738	Closed	-$628K	–	172
2022 Q1	$628K	Buy	+15,738	New	+$561K	﹤0.01%	146

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Pzena Investment Management's HALO Position: Q2 2026 in Review

Pzena Investment Management held its Halozyme (HALO) position steady in Q2 2026 at 4,049 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #147.

Pzena Investment Management first reported a position in HALO in Q1 2022 and has held it in 7 quarters since. The position peaked at $825K in Q4 2022. 398 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Pzena Investment Management held 4,049 shares of Halozyme worth $317K as of Q2 2026.
Pzena Investment Management left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Pzena Investment Management's portfolio in Q2 2026, its #147 holding.
Pzena Investment Management first reported a position in Halozyme in Q1 2022 and has held it in 7 quarters since.
Pzena Investment Management's Halozyme position peaked at $825K in Q4 2022.
398 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.